Towa Pharmaceutical Co Ltd
TSE:4553
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Towa Pharmaceutical Co Ltd
Operating Income
Towa Pharmaceutical Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
Operating Income
¥24.1B
|
CAGR 3-Years
47%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Income
¥480.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Income
¥317.4B
|
CAGR 3-Years
61%
|
CAGR 5-Years
34%
|
CAGR 10-Years
11%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Income
¥419.7B
|
CAGR 3-Years
35%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Income
¥611.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Income
¥394.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
5%
|
|
Towa Pharmaceutical Co Ltd
Glance View
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Kadoma-Shi, Osaka-Fu and currently employs 3,456 full-time employees. The company went IPO on 2004-04-05. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. The company is a drug with the same effect, usage and dosage. The firm is involved in the sale and outsourced manufacture of products and generic drugs. The firm is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The firm is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
See Also
What is Towa Pharmaceutical Co Ltd's Operating Income?
Operating Income
24.1B
JPY
Based on the financial report for Dec 31, 2025, Towa Pharmaceutical Co Ltd's Operating Income amounts to 24.1B JPY.
What is Towa Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
8%
Over the last year, the Operating Income growth was 5%. The average annual Operating Income growth rates for Towa Pharmaceutical Co Ltd have been 47% over the past three years , 7% over the past five years , and 8% over the past ten years .
